ACS Medicinal Chemistry Letters

Papers
(The median citation count of ACS Medicinal Chemistry Letters is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Call for Papers: Fungal Pathogens – Life Cycle, Infection, Host Immunity and Drug Discovery87
Novel Histone Acetyltransferase (HAT) Inhibitors for Treating Diseases87
In This Issue, Volume 14, Issue 574
Issue Publication Information56
Issue Editorial Masthead49
Substituted 2,3-Benzodiazepines Derivatives as Bromodomain BRD4 Inhibitors49
Targeting the “Undruggable” Driver Protein, KRASG12D, as Potential Therapy in Prostate Cancer48
Discovery of Selective Inhibitors of NaV1.7 Templated on Saxitoxin as Therapeutics for Pain48
Application of Deuterated N,N-Dimethyltryptamine in the Potential Treatment of Psychiatric and Neurological Disorders47
Issue Publication Information39
Emerging Techniques in Cancer Therapy: Precision Targeting for Improved Outcomes39
Cancer-Cell-Selective Targeting by Arylcyclopropylamine–Vorinostat Conjugates38
Novel PSMA-Targeting Radionuclide Peptidomimetics for Treating Prostate Cancer36
Design and Characterization of 1,3-Dihydro-2H-benzo[d]azepin-2-ones as Rule-of-5 Compliant Bivalent BET Inhibitors35
Discovery of Tumor-Targeted 6-Methyl Substituted Pemetrexed and Related Antifolates with Selective Loss of RFC Transport34
Conformationally Restricted Analogues of α-Galactosylceramide as Adjuvant in COVID-19 Subunit Vaccine34
From Virtual Screens to Cellular Target Engagement: New Small Molecule Ligands for the Immune Checkpoint LAG-334
Induction of Apoptosis in Cancer Cells by Glutathione Transferase Inhibitor Mediated Hydrophobic Tagging Molecules33
Clozapine as an E3 Ligand for PROTAC Technology32
Azapodophyllotoxin Causes Lymphoma and Kidney Cancer Regression by Disrupting Tubulin and Monoglycerols32
Psychiatric Treatments with Short-Duration Psychedelics and AI-Driven Behavioral Monitoring32
Novel Phosphorylpurinone Compounds for Treating Cancer31
Correction to “Sweet and Blind Spots in E3 Ligase Ligand Space Revealed by a Thermophoresis-Based Assay”30
Novel Heterocyclic Pyrimidine Derivatives as GSK3α Inhibitors28
Identification and Optimization of Small Molecule Pyrazolopyrimidine TLR7 Agonists for Applications in Immuno-oncology28
Macrocyclic Oxindole Peptide Epoxyketones─A Comparative Study of Macrocyclic Inhibitors of the 20S Proteasome27
Rational Control of Molecular Properties Is Mandatory to Exploit the Potential of PROTACs as Oral Drugs27
Exploration of a 14-3-3 PPI Pocket by Covalent Fragments as Stabilizers27
Comprehensive Strategies to Bicyclic Prolines: Applications in the Synthesis of Potent Arginase Inhibitors26
Novel Tetrahydrobenzo[b]pyrazolo[3,4-e][1,4]diazepine Compounds as Oxytocin Receptor Agonists for Treating Autism Spectrum Disorders25
Introducing the Potential Binding Interface between the TRAIL-Mimicking Peptide and DR5 via Alanine Scan25
Tryptamines and Mental Health: Activating the 5-HT Receptor for Therapeutic Potential25
Structure–Activity Relationship and In Silico Evaluation of cis- and trans-PCPA-Derived Inhibitors of LSD1 and LSD225
Bispecific Antibodies Produced via Chemical Site-Specific Conjugation Technology: AJICAP Second-Generation24
Contemporary Computational Applications and Tools in Drug Discovery24
Synthesis of Monofluorinated 7-Hydroxycoumarin-3-Carboxamides as Cell-Permeable Fluorescent Molecular Probes24
Discovery of Orally Bioavailable FGFR2/FGFR3 Dual Inhibitors via Structure-Guided Scaffold Repurposing Approach24
Methyl and Fluorine Effects in Novel Orally Bioavailable Keap1–Nrf2 PPI Inhibitor24
Novel Triazines as NLRP3 Inhibitors for Treating Multiple Diseases23
Thermal Stability and Utility of Dienes as Protecting Groups for Acrylamides23
Discovery of Heteroaryl Urea Isosteres for Formyl Peptide Receptor 2 Agonists23
Fused Bicyclic Heteroaryl Compounds as NLRP3 Inhibitors for Treating Asthma or COPD23
Targeting Cancer: A New Era in Cancer Therapy through Immune Fitness Modulation and KRAS Degradation23
Direct-to-Biology Accelerates PROTAC Synthesis and the Evaluation of Linker Effects on Permeability and Degradation23
Evaluating the Diversity and Target Addressability of DELs using Scaffold Analysis and Machine Learning22
The Synergistic Effects of 5-HT2A and TRP Agonism/Antagonism in Reducing Inflammation for Enhanced Mental and Physical Health22
Issue Editorial Masthead22
Issue Editorial Masthead22
Identification of gp120 Residue His105 as a Novel Target for HIV-1 Neutralization by Small-Molecule CD4-Mimics22
Novel 3-Cycloaminoindole Compounds as Serotonergic Psychedelic Agents for Treating Psychosis, Mental Illness, and CNS Disorders21
Discovery of a Potent and Selective Naphthyridine-Based Chemical Probe for Casein Kinase 221
Fragment Ligands of the m6A-RNA Reader YTHDF221
Novel Piperidinylpyridinylcarbonitrile Derivatives as QPCT and QPCTL Inhibitors for Treating Cancer21
Targeting Oncogenic Pathways: Advances in KRAS, CDK, EGFR, and PROTAC-Based Therapies20
Charting the Chemical Space of Acrylamide-Based Inhibitors of zDHHC2020
Pyrazole Ureas as Low Dose, CNS Penetrant Glucosylceramide Synthase Inhibitors for the Treatment of Parkinson’s Disease20
Novel Compounds as 5-HT2A Receptor Modulators for Treating Psychiatric and Neurological Disorders20
A Green-Absorbing, Red-Fluorescent Phenalenone-Based Photosensitizer as a Theranostic Agent for Photodynamic Therapy19
Identification of an Allene Warhead That Selectively Targets a Histidine Residue in the Escherichia coli Oxidoreductase Enzyme DsbA19
An Estrogen Receptor β Agonist with AR Antagonist Activity from a Modern Asymmetric De Novo Steroid Synthesis19
ACS Medicinal Chemistry Letters Patent Highlights: A Look Back19
Cell Permeability of Isomeric Macrocycles: Predictions and NMR Studies18
In Retrospect: Root-Cause Analysis of Structure–Activity Relationships in IRAK4 Inhibitor Zimlovisertib (PF-06650833)18
An Automated Purification Workflow Coupled with Material-Sparing High-Throughput 1H NMR for Parallel Medicinal Chemistry18
Advancing New Chemical Modalities into Clinical Studies18
Neuropharmacological Advances: Harnessing 5-HT2A Receptor Modulators and Psychoplastogens18
Machine Learning ADME Models in Practice: Four Guidelines from a Successful Lead Optimization Case Study18
Piperazinobenzodiazepinones: New Encephalitic Alphavirus Inhibitors via Ring Expansion of 2-Dichloromethylquinazolinones18
Discovery of Sovleplenib, a Selective Inhibitor of Syk in Clinical Development for Autoimmune Diseases and Cancers18
Discovery of N-(4-(Aminomethyl)phenyl)-5-methylpyrimidin-2-amine Derivatives as Potent and Selective JAK2 Inhibitors17
3AcFNP-59 for Positron Emission Tomography Imaging of Cholesterol Trafficking and Utilization17
Constructive On-DNA Abramov Reaction and Pudovik Reaction for DEL Synthesis17
Heparan Sulfate-Mimicking Glycopolymers Bind SARS-CoV-2 Spike Protein in a Length- and Sulfation Pattern-Dependent Manner17
Announcing the Early Career Board of ACS Medicinal Chemistry Letters17
Discovery and Characterization of a Chemical Probe for Cyclin-Dependent Kinase-Like 216
Thermal Degradation Kinetics and pH–Rate Profile of Verbascoside and Stability Improvement by Solid Lipid Nanoparticles16
Lead Optimization: Synthesis and Biological Evaluation of PBT-1 Derivatives as Novel Antitumor Agents16
SAR Study of 4,8-Disubstituted Pyrimido[5,4-d]pyrimidines Exhibiting Antitrypanosomal and Antileishmanial Activity16
N-Arylsulfonylated C-Homoaporphines as a New Class of Antiplatelet and Antimicrobial Agents16
In-Silico Screening-Based Discovery of New Natural eEF2K Inhibitors with Neuritogenic Activity16
Interleukin-17A Peptide Aptamers with an Unexpected Binding Moiety Selected by cDNA Display under Heterogenous Conditions16
Novel Papain-Like Protease Inhibitors for Treating Viral Infections, in Particular Coronavirus Infections16
Synthesis and Evaluation of Halogenated Pralidoximes in Reactivation of Organophosphate-Inhibited Cholinesterases16
Fragment-Based Dynamic Combinatorial Chemistry for Identification of Selective α-Glucosidase Inhibitors16
(−)-Epigallocatechin Gallate is a Noncompetitive Inhibitor of NAD Kinase15
Discovery of Pyridone-Substituted Triazolopyrimidine Dual A2A/A1 AR Antagonists for the Treatment of Ischemic Stroke15
Synthesis and Preclinical Evaluation of Novel 68Ga-DOTA-RBB as Potential PET Radiotracer for Imaging CDK4/6 in Tumors15
Enantioselective Bioreduction of Medicinally Relevant Nitrogen-Heteroaromatic Ketones15
The Growing Importance of Chirality in 3D Chemical Space Exploration and Modern Drug Discovery Approaches for Hit-ID15
Lathyrane Diterpenoids as Novel hPXR Agonists: Isolation, Structural Modification, and Structure–Activity Relationships15
Exploiting Solvent Exposed Salt-Bridge Interactions for the Discovery of Potent Inhibitors of SOS1 Using Free-Energy Perturbation Simulations15
Novel Furopyridine and Furopyrimidine Compounds as PI4K Inhibitors for Treating Malaria and Viral Infection15
Quantum Mechanics-Based Ranking of Predicted Proteolysis Targeting Chimeras-Mediated Ternary Complexes15
In Silico Optimized Stapled Peptides Targeting WASF3 in Breast Cancer15
Issue Publication Information14
Issue Publication Information14
Development of BET Inhibitors as Potential Treatments for Cancer: Optimization of Pharmacokinetic Properties14
Discovery of Potent and Oral Bioavailable MAT2A Inhibitors for the Treatment of MTAP-Deleted Tumors14
Issue Publication Information14
Issue Publication Information14
Issue Publication Information14
Lead Optimization of Small Molecule ENL YEATS Inhibitors to Enable In Vivo Studies: Discovery of TDI-1105514
Targeted Degradation of Androgen Receptor for the Potential Treatment of Prostate Cancer14
Issue Publication Information14
Novel Imidazotriazine Derivatives as IL-17 Modulators for Treating Inflammatory and Autoimmune Disorders14
Photoaffinity Probe Reveals the Potential Target of Harringtonolide for Cancer Cell Migration Inhibition14
Novel Small Molecule RNA m6A Demethylase AlkBH5 Inhibitors for Treating Cancer14
Issue Editorial Masthead14
Design, Synthesis, and Biological Activity of l-1′-Homologated Adenosine Derivatives13
Hybrids of Membrane-Translocating Antimicrobial Peptides Show Enhanced Activity through Membrane Permeabilization13
The BASHY Platform Enables the Assembly of a Fluorescent Bortezomib–GV1001 Conjugate13
Exploring the Therapeutic Potential of Entheogens in Postoperative Cognitive Decline and Psychological Resilience13
SiRNAs with Neutral Phosphate Triester Hydrocarbon Tails Exhibit Carrier-Free Gene-Silencing Activity13
Ir(III) Complex Dimer Nanoparticles for Photodynamic Therapy13
Lipase-Catalyzed Synthesis and Biological Evaluation of N-Picolineamides as Trypanosoma cruzi Antiproliferative Agents13
Identification and In Silico Binding Study of a Highly Potent DENV NS2B-NS3 Covalent Inhibitor13
Small Molecules Blocking the Assembly of TCAB1 and Telomerase Complexes: Lead Discovery and Biological Activity13
Introducing Conformational Restraints on 25CN-NBOH: A Selective 5-HT2A Receptor Agonist13
Discovery of First-in-Class BAZ2A/B and BAZ2B-Selective Degraders13
Synthesis, Anti-Plasmodial Activities, and Mechanistic Insights of 4-Aminoquinoline-Triazolopyrimidine Hybrids13
Discovery of Novel Pyrazolopyrimidines as Potent, Selective, and Orally Bioavailable Inhibitors of ALK213
Structure–Activity Relationships for the N-Me- Versus N-H-Amide Modification to Macrocyclic ent-Verticilide Antiarrhythmics13
Issue Editorial Masthead13
Spiro(isobenzofuranazetidine) Compounds for Treating Autoimmune Diseases13
Novel Plasma Kallikrein Inhibitors for Treating Hereditary Angioedema, Diabetic Macular Edema, and Diabetic Retinopathy13
In the Quest for Potent and Selective Malic Enzyme 3 Inhibitors for the Treatment of Pancreatic Ductal Adenocarcinoma13
Indole-Containing Pyrazino[2,1-b]quinazoline-3,6-diones Active against Plasmodium and Trypanosomatids13
Improving the Adjuvanticity of Small Molecule Immune Potentiators Using Covalently Linked NF-κB Modulators12
Issue Editorial Masthead12
Amino-cyclohexane Carboxylic Acid Inhibitors of Arginase12
In This Issue, Volume 12, Issue 712
Re-evaluation of Cyclic Peptide Binding to Neurotensin Receptor 1 by Shifting the Peptide Register during Synthesis12
Issue Publication Information12
2-Imidazole as a Substitute for the Electrophilic Group Gives Highly Potent Prolyl Oligopeptidase Inhibitors12
Discovery of CVN636: A Highly Potent, Selective, and CNS Penetrant mGluR7 Allosteric Agonist12
Application of Rapidly Accelerating Fibrosarcoma Protein Degraders in Drug Discovery12
In This Issue, Volume 13, Issue 112
Recent Developments in Mass Spectrometry to Support Next-Generation Synthesis and Screening12
Peripherally Restricted Fused Heterocyclic Peptidomimetic Multifunctional Opioid Agonists as Novel, Potent Analgesics12
Novel Pyrimidinyl Sulfonamide Derivatives as GPR17 Modulators12
Enantiopure Benzofuran-2-carboxamides of 1-Aryltetrahydro-β-carbolines Are Potent Antimalarials In Vitro12
Issue Editorial Masthead12
Targeting KRAS G12D Mutant for the Potential Treatment of Pancreatic Cancer12
Issue Publication Information12
Synthesis and Evaluation of Benzylamine Inhibitors of Neuropathogenic Naegleria fowleri “Brain-Eating” Amoeba11
Discovery of 5,7-Dihydro-6H-pyrrolo[2,3-d]pyrimidin-6-ones as Highly Selective CDK2 Inhibitors11
Reducing Self-Assembly by Increasing Net Charge: Effect on Biological Activity of Mastoparan C11
Fragment-Based Discovery of Drug-like LRH-1 Agonists11
Accelerated Discovery of Macrocyclic CDK2 Inhibitor QR-6401 by Generative Models and Structure-Based Drug Design11
Discovery of New Binders for DCAF1, an Emerging Ligase Target in the Targeted Protein Degradation Field11
Novel Nonpeptide as Oxytocin Receptor Agonist11
Structure–Activity Relationship Study of 1H-Pyrrole-3-carbonitrile Derivatives as STING Receptor Agonists11
Synthesis and Evaluation of Novel meso-Tetraphenyltetrabenzoporphyrins for Photodynamic Therapy11
A New Highly Deuterated [18F]AV-45, [18F]D15FSP, for Imaging β-Amyloid Plaques in the Brain11
Innovative Psychedelic Therapies: Harnessing 5-MeO-DMT and DMT for Mental Health Treatment11
Inhibitors of the Cyclic GMP-AMP Synthase (cGAS) as Potential Treatment for Autoimmune and Inflammatory Diseases11
Beyond 20 in the 21st Century: Prospects and Challenges of Non-canonical Amino Acids in Peptide Drug Discovery11
Design, Synthesis, and Evaluation of 8-(o-Tolyl)quinazoline Derivatives as Small-Molecule PD-1/PD-L1 Antagonists11
Synthesis and Monoamine Oxidase Inhibitory Activity of Halogenated Flavones11
Identification of Boc2Lys-Linked Ethacrynic Acid and Its Analogues As Efficient Glutathione S-Transferase Degraders11
Tetrazole Derivatives as TRPA1 Inhibitors for Treating Idiopathic Lung Disease or Cough11
Enantioselective Synthesis and Profiling of Potent, Nonlinear Analogues of Antimalarial Tetraoxanes E209 and N20511
Potentiometric Determination of Acid Dissociation Constants (pKa) for an Anticancer Pyrrole-Imidazole Polyamide11
N-Biphenyl Pyrrolinones and Dibenzofurans as RNA-Binding Protein LIN28 Inhibitors Disrupting the LIN28–Let-7 Interaction11
Discovery of Dolastatinol: A Synthetic Analog of Dolastatin 10 and Low Nanomolar Inhibitor of Tubulin Polymerization11
Targeting KRAS Mutant Protein Inhibitor for Potential Treatment in Cancer10
The Inhibitors of Mucosa-Associated Lymphoid Tissue Lymphoma Translocation Protein 1 (MALT-1) Protease as Potential Treatment of ABC-DLBCL and Similar Diseases10
Discovery of Selective Aldehyde Dehydrogenase Inhibitors for the Treatment of Cancer10
Synthesis of Benzoazepine Derivatives via Azide Rearrangement and Evaluation of Their Antianxiety Activities10
In This Issue, Volume 12, Issue 1110
Inhibitors of Nav1.7 for the Treatment of Pain10
Development of BODIPY FL SNS 032 as a Versatile Probe for Constitutive Androstane Receptor and Multiple Kinases10
Steroid–Quinoline Hybrids for Disruption and Reversion of Protein Aggregation Processes10
4-Oxo-β-lactams as Covalent Inhibitors of the Mitochondrial Intramembrane Protease PARL10
Issue Publication Information10
How a Blockchain Approach Can Improve Data Reliability in the COVID-19 Pandemic10
Bioisostere Effects on the EPSA of Common Permeability-Limiting Groups10
Novel Pyridazin-3(2H)-one-Based Guanidine Derivatives as Potential DNA Minor Groove Binders with Anticancer Activity10
ACS Medicinal Chemistry Letters: An Innovation Ten Years in the Making10
Biological Effects of Modifications of the Englerin A Glycolate10
9,10-Bis[(4-(2-hydroxyethyl)piperazine-1-yl)prop2-yne-1-yl]anthracene: G-Quadruplex Selectivity and Anticancer Activity10
Synthesis and Determination of Anticancer Activity of Dicobalt Hexacarbonyl 2′-Deoxy-5-alkynylfuropyrimidines10
Mining Druggable Sites in Influenza A Hemagglutinin: Binding of the Pinanamine-Based Inhibitor M09010
Issue Publication Information10
Novel Aminocyclobutanes as Monoacylglycerol Lipase Modulators10
Decarboxylative Cross-Coupling: A Radical Tool in Medicinal Chemistry10
Optimization of Brigatinib as New Wild-Type Sparing Inhibitors of EGFRT790M/C797S Mutants10
Pioneering Changes in Psychiatry: Biomarkers, Psychedelics, and AI10
Intramolecular Ring-Opening Decomposition of Aryl Azetidines10
A Warhead Substitution Study on the Coronavirus Main Protease Inhibitor Nirmatrelvir10
Potent, Selective, and Orally Bioavailable Quinazoline-Based STK17A/B Dual Inhibitors10
Discovery of Non-Covalent Inhibitors for SARS-CoV-2 PLpro: Integrating Virtual Screening, Synthesis, and Experimental Validation10
Discovery of a Novel Photocaged PI3K Inhibitor Capable of Real-Time Reporting of Drug Release10
Discovery of Novel Hydroxyimine-Tethered Benzenesulfonamides as Potential Human Carbonic Anhydrase IX/XII Inhibitors9
Novel Lactams as Cbl-b Inhibitors for Treating Cancer9
Design, Construction, and Screening of Diversified Pyrimidine-Focused DNA-Encoded Libraries9
Identification, Synthesis, and Characterization of a Major Circulating Human Metabolite of TRPV4 Antagonist GSK27987459
Novel Piperidine Substituted Pyrazolopyrimidine Derivatives as SGK1 Inhibitors for Treating Cardiovascular Diseases9
BTZ-Derived Benzisothiazolinones with In Vitro Activity against Mycobacterium tuberculosis9
Allostery Illuminated: Harnessing AI and Machine Learning for Drug Discovery9
RNA: Opening New Doors in Medicinal Chemistry, a Special Issue9
A Neutral Flavin–Triphenylamine Probe for Mitochondrial Bioimaging under Different Microenvironments9
Novel Thienopyrrole Compounds for Treating Autoimmune Diseases and Inflammatory Conditions9
Selective Wee1 Inhibitors Led to Antitumor Activity In Vitro and Correlated with Myelosuppression9
MALT1 Inhibitors for Treating Cancer and Immunological Diseases9
Modulation of KRAS Mutant by Inhibiting PLK1 Kinase in Cancer Therapeutics9
Development of Potent 3-Br-isoxazoline-Based Antimalarial and Antileishmanial Compounds9
Structure-Based Design of Novel TLR7/8 Agonist Payloads Enabling an Immunomodulatory Conjugate Approach9
Inhibitors of Interleukin 4 Induced Protein 1 (IL4I1) as Potential Treatment for Cancer9
Issue Publication Information9
Relevance of the Trillion-Sized Chemical Space “eXplore” as a Source for Drug Discovery9
Recent Discovery of PARP7 Inhibitors as Anticancer Agents9
Novel 2-Pyrrolidone Derivatives as Negative Allosteric Modulators of GluN2B-Containing NMDA Receptors9
Issue Publication Information9
Correction to “Study of Chalcogen Aspirin Derivatives with Carbonic Anhydrase Inhibitory Properties for Treating Inflammatory Pain”9
Novel Compounds as NLRP3 Inhibitors for Treating Asthma or COPD9
DNA-Encoded Macrocyclic Peptide Libraries Enable the Discovery of a Neutral MDM2–p53 Inhibitor9
Discovery of Novel Pyrimidine Derivatives as Human Pin1 Covalent Inhibitors9
In This Issue, Volume 15, Issue 49
Targeting the Inhibition of B-Cell Lymphoma 2 Protein for the Treatment of Cancer8
Integrated Advancements in Neuroplasticity, Psychedelic Therapeutics, and AI-Driven Innovations for Precision Medicine8
Design and Assessment of First-Generation Heterobifunctional PPARα/STING Modulators8
Structure–Activity Relationship of Anti-Mycobacterium abscessus Piperidine-4-carboxamides, a New Class of NBTI DNA Gyrase Inhibitors8
Addition to “The Death of the Strategy of Classical Chiral Switches Is an Exaggeration”8
Call for Papers: Exploring the Use of AI/ML Technologies in Medicinal Chemistry and Drug Discovery8
Issue Publication Information8
Novel 6-Substituted-3-Phenylisoindolin-1-ones as Cbl-B Inhibitors for Treating Cancer8
Investigation of Isobactin Analogues of Teixobactin8
Development of Conformationally Restricted Negamycin Derivatives for Potent Readthrough Activity8
Evaluation of the Indazole Analogs of 5-MeO-DMT and Related Tryptamines as Serotonin Receptor 2 Agonists8
Discovery of First-in-Class Small Molecule Inhibitors of Lymphocyte Activation Gene 3 (LAG-3)8
Ligand Design with Accelerated Disulfide Formation with Serum Albumin to Extend Blood Retention8
Synthesis of Marine-Inspired Multifaceted DNA Damaging Spirooxindoles Combating NSCLC and Associated Bacterial Infection8
Integrating Neuroprotective and Anti-inflammatory Strategies in the Development of PI3K Inhibitors for Enhanced Cancer Therapy8
Novel AHR Agonists for Treating Psoriasis8
Novel Macrocyclic Antagonists of the CGRP Receptor Part 2: Stereochemical Inversion Induces an Unprecedented Binding Mode8
Application of Compositions Comprising a KRAS G12C Inhibitor and an EGFR Inhibitor for the Potential Treatment of Cancer8
Issue Publication Information8
Structural Evaluations of a Selective Human STINGA230 Agonist and Its Use in Macrophage Immunotherapies8
Cytosolic Enzymes Generate Cannabinoid Metabolites 7-Carboxycannabidiol and 11-Nor-9-carboxytetrahydrocannabinol8
Novel Histone Deacetylase Inhibitors for Treating HIV Infection8
Total Synthesis as Training for Medicinal Chemistry8
Bicyclic Inhibitors of Branched-Chain α-Keto Acid Dehydrogenase Kinase (BDK) with In Vivo Activity8
A Tiny Pocket Packs a Punch: Leveraging Pyridones for the Discovery of CNS-Penetrant Aza-indazole IRAK4 Inhibitors8
Innovations in Precision Oncology: Biomarker-Driven Approaches for Enhanced Cancer Therapy8
Insight on Some Newly Synthesized Trisubstituted Imidazolinones as VEGFR-2 Inhibitors8
Exploring the 1-(4-Nitrophenyl)-3-arylprop-2-en-1-one Scaffold for the Selective Inhibition of Monoamine Oxidase B8
Identification of 5-Thiocyanatothiazol-2-amines Disrupting WDR5-MYC Protein–Protein Interactions8
Heterocyclic Compounds as Dihydroorotate Dehydrogenase Inhibitors for Treating Acute Myelogenous Leukemia (AML)8
Malaria Box-Inspired Discovery of N-Aminoalkyl-β-carboline-3-carboxamides, a Novel Orally Active Class of Antimalarials8
0.092166900634766